Nemucore Medical Innovations, Inc.
https://www.nemucore.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Nemucore Medical Innovations, Inc.
Lilly Reacquires Aurora Kinase Inhibitor Via AurKa Buy For $110m
Many Aurora kinase inhibitors have entered development, but while none have had a successful end, Lilly believes the specificity of AurKa's AK-01 will make it a safer drug. The asset fits well into Lilly's oncology strategy, which includes both targeted therapies and immuno-oncology drugs.
Start-Up Execs On The Move, June 2016
Recent executive-level hires and director appointments at venture capital firms and biopharma and medtech start-ups.
Start-Up Execs On The Move, January 2016
Recent executive-level hires and director appointments at venture capital firms and biopharma and medtech start-ups.
Venture Funding Deals, January 2016
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging life science companies that have received venture funding, including companies within the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors. This month’s column covers deals announced November through December 2015.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice